Latest Breaking News On - Melanoma research alliance medical advisory panel - Page 1 : vimarsana.com

04.01.2024 - WATERTOWN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) - Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of novel, conditionally activated INDUKINE therapeutics .

United-states
American
Williamm-scholl
Ellen-lubman
Michael-atkins
Melanoma-research-alliance-medical-advisory-panel
Society-for-the-immunotherapy-of-cancer
Verge-scientific-communications
Professor-at-harvard-medical-school
Advisory-council
Cancer-center
Werewolf-therapeutics-inc